SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-095516
Filing Date
2021-03-26
Accepted
2021-03-26 09:02:14
Documents
48
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d33379d10k.htm 10-K 941433
2 EX-23.1 d33379dex231.htm EX-23.1 1440
3 EX-31.1 d33379dex311.htm EX-31.1 10702
4 EX-31.2 d33379dex312.htm EX-31.2 10365
5 EX-32.1 d33379dex321.htm EX-32.1 3575
6 EX-32.2 d33379dex322.htm EX-32.2 3582
  Complete submission text file 0001193125-21-095516.txt   3478652

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT inti-20201231.xml EX-101.INS 523328
8 XBRL TAXONOMY EXTENSION SCHEMA inti-20201231.xsd EX-101.SCH 31042
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inti-20201231_cal.xml EX-101.CAL 24953
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inti-20201231_def.xml EX-101.DEF 161561
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE inti-20201231_lab.xml EX-101.LAB 287741
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inti-20201231_pre.xml EX-101.PRE 223064
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 21774908
SIC: 8731 Services-Commercial Physical & Biological Research